openPR Logo
Press release

Interventional Oncology Solutions Market Ablation Radiofrequency Ablation, Cryo Ablation Therapy

07-24-2018 04:24 PM CET | Health & Medicine

Press release from: Pharamceutical

Interventional Oncology Solutions Market Ablation

Interventional oncology is a field of medical science, which includes treatment and diagnosis of cancer and other problems related to cancer using minimally invasive procedures. Interventional oncology uses various techniques such as Ultrasound, computed tomography, X-ray, and magnetic resonance imaging (MRI) to treat tumors located in various organs of the body. Interventional oncology procedures are usually used to treat metastatic or primary cancer. These procedures can be used to treat cancer in pancreas, liver, lung, breast, prostrate, kidney, and bones. Interventional oncology procedures are segmented into two procedures i.e. diagnostic and therapeutic. Therapeutic procedures can be further categorized into ablation techniques and embolization techniques. Ablation techniques uses some form of heat to destroy tumor. Embolization Technique occludes blood vessels, which feed tumors and further destroy the tumor by means of ischemia. Both these procedures are minimally invasive and there is minimal pain, complications, and discomfort with rapid recovery.

Click To Continue Reading On Interventional Oncology Solutions Market
https://www.coherentmarketinsights.com/ongoing-insight/interventional-oncology-solutions-market-1884

Interventional Oncology Solutions Market Drivers:-
Increasing popularity of minimal invasive procedures due to advantages such as minimal risk of infection, shorter stay in the hospitals, minimal complications, minimal pain, and faster recovery as compared to invasive surgeries, is a major factor supporting the global interventional oncology solutions market growth over the forecast period. Moreover, increasing product launches is expected to aid in growth in interventional oncology solutions market size. For instance, in 2017, Terumo Corporation, a Japan-based company, launched Quirem Spheres microspheres. This is used to treat solid liver tumors, which cannot be removed by surgery completely. Microspheres consists of a radioactive isotope Holium-166. Quirem Spheres and can also be visualized in low concentrations by means of SPECT (Single Photon Emission Computed Tomography) and MRI. This feature allows doctors to carefully assess distribution of microspheres in the organs such as liver, which enables in accurate assessment of treatment after SIRT (Selective Internal radiation Therapy) procedure. Half-life of Quirem Spheres is 26.8 hours, which means that within the first 4 days more than 90% of the radiation is delivered, which is followed by implantation procedure.

Get The Holistic SAMPLE With Research Methodology:
https://www.coherentmarketinsights.com/insight/request-sample/1884

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com
Visit our news Website: https://www.coherenttimes.org

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Interventional Oncology Solutions Market Ablation Radiofrequency Ablation, Cryo Ablation Therapy here

News-ID: 1143627 • Views: 184

More Releases from Pharamceutical

Congestive Heart Failure Drugs Market, by Drug Type ACE Inhibitors, Angiotensin …
Major driver for growth of the congestive heart failure drugs market is the robust pipeline of drugs under development. For instance, furosemide injection solution (SCP-101) sponsored by Johns Hopkins University in collaboration with Scpharmaceuticals Inc. was in phase 2 clinical trials in 2015, this injection is indicated for treatment of heart failure. Furosemide and Azosemide sponsored by Hyogo College of Medicine has completed phase 4 clinical trials in 2016, these
New improved medication with lesser side effects will drive the insomnia therape …
Benzodiazepines (BZP) such as temazepam and diazepam are the commonly prescribed medication for insomnia. Though these medications are effective, prolonged use of these drugs may cause cognitive impairment, dependency and addiction. The launch of novel drugs such as Intermezzo (2014), tasimelteon (2014) have created a meteoric growth in G7 countries in the insomnia therapeutics and is expected market over the forecast period. Intermezzo (2014), are used in small doses and administered
Antiepileptic Drugs Market - Global Industry Insights,
Antiepileptic Drugs Market Regional Analysis North America and Europe are expected to witness significant growth in the market over the forecast period due to robust pipeline for epilepsy treatment and individual efforts by leading manufacturers. For instance, Pfizer, Inc. entered into partnership with Epilepsy Foundation to find solutions for generic forms of epilepsy and associated neurological disorders in 2014. Asia Pacific region is expected to show positive developments over the forecast
Clinical Trial Supply and Logistics Market - Global Forecast And Outlook To 2026
Quantity of ancillary supplies and diverse vendors to produce those supplies have significantly increased in the market, owing to rising demand for developing and producing clinical supplies from end user manufacturers or investigators for global studies in a cost-efficient manner. According to an article published in the Applied Clinical Trials website, 2016, there are around 40,000 unique investigators worldwide conducting at least one FDA-regulated clinical trial. Furthermore, increasing prevalence of

All 5 Releases


More Releases for Interventional

Interventional Radiology Market Current Overview of 2025
Global Interventional Radiology Market: Overview Interventional radiology (IR) is a medical sub-specialty of radiology, which uses minimally invasive image-guided procedures and methods to diagnose and treat various diseases. IR techniques include a range of radiological image guidance methods such as ultrasound, X-ray fluoroscopy, computed tomography (CT), and magnetic resonance imaging (MRI). IR has transformed every sphere of patient management process and has gained traction among clinicians and patients due to
Global Interventional Neurology Market - Industry Overview
Market players need to address demand-shift in devices and procedural techniques The global Interventional neurology market is undergoing a demand-shift in terms of products and techniques to treat stroke and aneurysms. For instance, demand for bare platinum coils is growing at a rapid pace as compared to that for coated coils. This is mainly due to high costs of coated coils and their less improved clinical outcomes compared to bare platinum
10-11-2017 | Health & Medicine
TMR
Interventional Radiology Market Size, Share, Analysis & Forecast
The global interventional radiology market features a largely consolidated competitive landscape, with the top five players accounting for around 60% of the market in 2015, observes a recent report by Transparency Market Research. These top five vendors, namely Philips Healthcare, Hitachi Medical Corporation, GE Healthcare, Toshiba Medical Systems Corporation, and Siemens Healthcare lead the global market owing to diversified product portfolios, extensive geographical presence, and acquisition strategies. Strong new product development capabilities
China Interventional Radiology Market Research Report 2017
This report studies Interventional Radiology in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering Medtronic PLC Boston Scientific Corporation Abbott Vascular Cordis Corporation C.R. Bard B.Braun Melsungen AG Biosensors International Group Stryker Corporation Terumo Corporation Cook Medical Fill the form for an exclusive sample of this report @ http://www.qyresearchreports.com/sample/sample.php?rep_id=982656&type=E Market Segment by Regions (provinces), covering South China East China Southwest China Northeast China North China Central China Northwest China Split by product Type, with production, revenue,
Global Interventional Radiology Market Research Report 2024
The global interventional radiology market features a largely consolidated competitive landscape, with the top five players accounting for around 60% of the market in 2015, observes a recent report by Transparency Market Research. These top five vendors, namely Philips Healthcare, Hitachi Medical Corporation, GE Healthcare, Toshiba Medical Systems Corporation, and Siemens Healthcare lead the global market owing to diversified product portfolios, extensive geographical presence, and acquisition strategies. Strong new product
Interventional Neurology Market - Global Industry Analysis 2024
Neurovascular conditions such as stroke and aneurysms are generally treated with tissue plasminogen activators (tPAs). However, use of neurointerventional devices along with the medication therapy is more effective in removing clots and reducing the risk of early recurrence of the condition. Interventional neurology technology has been evolving rapidly, which is resulting in demand shift from clipping to coiling, coated to bare platinum coils, and so on. Get Free PDF Research Brochure